February 3, 2026 · Form 4 insider transaction
Grant-Kels Jane M. bought 51,525 shares of Veradermics, Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.